Why is Mukka Proteins falling/rising?

As of 02-Sep, Mukka Proteins Ltd is currently priced at 27.84, reflecting an increase of 0.84 or 3.11%. The stock has shown a positive trend recently, gaining 4.27% over the last two days, although it has underperformed its sector by 3.61% today. In terms of longer-term performance, the stock has generated a return of -39.82% over the past year, while its profits have decreased by 34%. The company has also faced challenges, including a high Debt to EBITDA ratio of 4.36 times, indicating low ability to service debt, and it has reported negative results for the last six consecutive quarters, with significant declines in net sales and profit after tax. In the broader market context, the stock has outperformed the Sensex in the past week, gaining 4.07% compared to the benchmark's decline of 0.78%. However, over the longer term, Mukka Proteins has underperformed against the BSE500 and has seen a decline in institutional investor participation, with a decrease of 0.65% in their stake. This suggests a lack of confidence among institutional investors, who typically have more resources to analyze company fundamentals. Overall, while there are some short-term gains, the long-term outlook remains concerning due to poor financial performance and high debt levels.